# XORTX Therapeutics Inc.: Form 6-K, filed Oct 26, 2022

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2022-10-26
- Accepted by EDGAR: Oct 26, 2022, 07:52 ET
- Period: 2022-10-26
- Accession: 0001171843-22-006745
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184322006745/f6k_102622.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184322006745/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184322006745/f6k_102622.htm

Filed Oct 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-006745. Last ingested by Listed: Nov 14, 2026, 22:48 ET. No prices; not investment advice.
